Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 4;57(11):1201.
doi: 10.3390/medicina57111201.

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome

Affiliations

Burden of Comorbidities in Patients with OSAS and COPD-OSAS Overlap Syndrome

Athanasios Voulgaris et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Obstructive sleep apnea syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are usually associated with multi-morbidity. The aim of this study was to retrospectively investigate the prevalence of comorbidities in a cohort of patients with OSAS and COPD-OSAS overlap syndrome (OS) patients and to explore differences between these two groups. Materials and Methods: Included were consecutive OS patients and OSAS patients who had been referred to our sleep laboratory, and were matched in terms of sex, age, BMI, and smoking history. Presence of comorbidities was recorded based on their medical history and after clinical and laboratory examination. Results: The two groups, OS patients (n = 163, AHI > 5/h and FEV1/FVC < 0.7) and OSAS patients (n = 163, AHI > 5/h, and FEV1/FVC > 0.7), did not differ in terms of apnea hypopnea index (p = 0.346), and oxygen desaturation index (p = 0.668). Compared to OSAS patients, OS patients had lower average SpO2 (p = 0.008) and higher sleep time with oxygen saturation <90% (p = 0.002) during sleep, and lower PaO2 (p < 0.001) and higher PaCO2 (p = 0.04) in wakefulness. Arterial hypertension was the most prevalent comorbidity for both OS and OSAS, followed by dyslipidemia, cardiovascular disease (CVD) and diabetes. OS was characterized by a higher prevalence of total comorbidities (median (IQR):2 (1-3) vs. 2 (1-2), p = 0.033), which was due to the higher prevalence of CVD (p = 0.016) than OSAS. No differences were observed in other comorbidities. Conclusions: In OS patients, nocturnal hypoxia and impaired gas exchange in wakefulness are more overt, while a higher burden of CVD is observed among them in comparison to sex-, age- and BMI-matched OSAS patients.

Keywords: cardiovascular disease; chronic obstructive pulmonary disease; comorbidities; obstructive sleep apnea syndrome; overlap syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The study flowchart. BMI: body mass index; COPD: chronic obstructive pulmonary disease; OS: overlap syndrome; OSAS: obstructive sleep apnea syndrome; PFTs: pulmonary function testing; PSG: polysomnography.

Similar articles

Cited by

References

    1. Voulgaris A., Archontogeorgis K., Steiropoulos P., Papanas N. Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Obstructive Sleep Apnoea Syndrome and Overlap Syndrome. Curr. Vasc. Pharmacol. 2021;19:285–300. doi: 10.2174/1570161118666200318103553. - DOI - PubMed
    1. Economic Burden of Undiagnosed Sleep Apnea in U.S. is Nearly $150B. American Academy of Sleep Medicine—Association for Sleep Clinicians and Researchers. 2016. [(accessed on 23 November 2019)]. Available online: https://aasm.org/economic-burden-of-undiagnosed-sleep-apnea-in-u-s-is-ne...
    1. Gershon A.S., Thiruchelvam D., Chapman K.R., Aaron S.D., Stanbrook M.B., Bourbeau J., Tan W., To T., Canadian Respiratory Research Network Health Services Burden of Undiagnosed and Overdiagnosed COPD. Chest. 2018;153:1336–1346. doi: 10.1016/j.chest.2018.01.038. - DOI - PubMed
    1. Veasey S.C., Rosen I.M. Obstructive Sleep Apnea in Adults. N. Engl. J. Med. 2019;380:1442–1449. doi: 10.1056/NEJMcp1816152. - DOI - PubMed
    1. Mirza S., Clay R.D., Koslow M.A., Scanlon P.D. COPD Guidelines: A Review of the 2018 GOLD Report. Mayo. Clin. Proc. 2018;93:1488–1502. doi: 10.1016/j.mayocp.2018.05.026. - DOI - PubMed

MeSH terms